All the news articles and press releases in one place.

Search
Date / Time Source Ticker Company Sector Market Cap Announcement
31May19 07:00 RNS AGL:LON ANGLE plc Health £31.9m Positive Results from FDA Clinical Study
26Apr19 07:00 RNS AGL:LON ANGLE plc Health £31.9m IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
18Apr19 07:00 RNS-R AGL:LON ANGLE plc Health £31.9m Parsortix used in new cancer assessment technique
12Apr19 07:00 RNS-R AGL:LON ANGLE plc Health £31.9m LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04Apr19 07:00 RNS AGL:LON ANGLE plc Health £31.9m AACR 2019
11Mar19 07:00 RNS LGEN:LON, AGL:LON ANGLE plc, Legal & General Group Plc Various Various Holding(s) in Company
07Mar19 07:00 RNS AGL:LON ANGLE plc Health £31.9m ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28Feb19 07:00 RNS AGL:LON ANGLE plc Health £31.9m FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25Feb19 07:00 RNS AGL:LON ANGLE plc Health £31.9m CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11Feb19 07:00 RNS AGL:LON ANGLE plc Health £31.9m Research into role of immune cells in cancer
31Jan19 07:00 RNS AGL:LON ANGLE plc Health £31.9m Interim Results
29Jan19 07:00 RNS-R AGL:LON ANGLE plc Health £31.9m NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
10Jan19 16:01 RNS AGL:LON ANGLE plc Health £31.9m BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09Jan19 07:00 RNS AGL:LON ANGLE plc Health £31.9m Notice of Results
21Dec18 07:00 RNS AGL:LON ANGLE plc Health £31.9m Issue of LTIP Options and Share Options
28Nov18 07:00 RNS-R AGL:LON ANGLE plc Health £31.9m LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13Nov18 17:10 RNS AGL:LON ANGLE plc Health £31.9m Holding(s) in Company
05Nov18 07:00 RNS AGL:LON ANGLE plc Health £31.9m Acquisition of outstanding shares
01Nov18 07:00 RNS AGL:LON ANGLE plc Health £31.9m Appointment of Dr Jan Groen as NED
30Oct18 16:21 RNS AGL:LON ANGLE plc Health £31.9m Result of AGM
29Oct18 07:00 RNS AGL:LON ANGLE plc Health £31.9m PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25Oct18 07:00 RNS AGL:LON ANGLE plc Health £31.9m Good Progress with FDA Studies
09Oct18 07:00 RNS AGL:LON ANGLE plc Health £31.9m Notice of AGM
25Jul18 07:00 RNS AGL:LON ANGLE plc Health £31.9m Preliminary Results for year ended 30 April 2018
24Jul18 17:42 RNS AGL:LON ANGLE plc Health £31.9m EIS/VCT Advance Assurance and Total Voting Rights
18Jul18 10:34 RNS AGL:LON ANGLE plc Health £31.9m Result of General Meeting
02Jul18 07:00 RNS AGL:LON ANGLE plc Health £31.9m Notice of Preliminary Results
25Jun18 18:20 RNS AGL:LON ANGLE plc Health £31.9m Results of Fundraising
25Jun18 14:58 RNS AGL:LON ANGLE plc Health £31.9m Close of Accelerated Bookbuild
25Jun18 07:50 RNS AGL:LON ANGLE plc Health £31.9m Proposed Placing of New Ordinary Shares
04Jun18 07:00 RNS AGL:LON ANGLE plc Health £31.9m ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
19Apr18 07:00 RNS AGL:LON ANGLE plc Health £31.9m Breakthrough Research with Parsortix
05Apr18 07:00 RNS AGL:LON ANGLE plc Health £31.9m First patient enrolled in FDA study
26Mar18 07:00 RNS AGL:LON ANGLE plc Health £31.9m Research Update
06Feb18 07:00 RNS AGL:LON ANGLE plc Health £31.9m ANGLE plc: RESEARCH GRANT FROM ABBOTT
31Jan18 07:00 RNS AGL:LON ANGLE plc Health £31.9m Interim Results
10Jan18 10:16 RNS AGL:LON ANGLE plc Health £31.9m Notice of Results
08Jan18 07:00 RNS AGL:LON ANGLE plc Health £31.9m ANGLE plc:Prostate cancer ARV7 treatment biomarker
27Dec17 11:49 RNS AGL:LON ANGLE plc Health £31.9m Holding(s) in Company
12Dec17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Transfer of Lock-in Shares
08Dec17 07:00 RNS AGL:LON ANGLE plc Health £31.9m PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER
23Nov17 07:00 RNS AGL:LON ANGLE plc Health £31.9m PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER
17Nov17 16:06 RNS AGL:LON ANGLE plc Health £31.9m Holding(s) in Company
16Nov17 08:23 RNS AGL:LON ANGLE plc Health £31.9m Total Voting Rights and Covington Subscription
06Nov17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Holding(s) in Company
06Nov17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Holding(s) in Company
06Nov17 07:00 RNS LGEN:LON, AGL:LON ANGLE plc, Legal & General Group Plc Various Various Holding(s) in Company
02Nov17 10:04 RNS AGL:LON ANGLE plc Health £31.9m Holding(s) in Company
01Nov17 08:12 RNS AGL:LON ANGLE plc Health £31.9m ANGLE: Completion of Fundraising and Acquisition
31Oct17 14:18 RNS AGL:LON ANGLE plc Health £31.9m Result of AGM
30Oct17 10:31 RNS AGL:LON ANGLE plc Health £31.9m Result of General Meeting
26Oct17 08:10 RNS AGL:LON ANGLE plc Health £31.9m Total Voting Rights
23Oct17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Parsortix harvests cancer cells from bone marrow
20Oct17 15:05 RNS AGL:LON ANGLE plc Health £31.9m Notice of AGM
12Oct17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Proposed further subscription for £2.8 million
09Oct17 07:02 RNS AGL:LON ANGLE plc Health £31.9m CTCs harvested with Parsortix grown in laboratory
09Oct17 07:01 RNS AGL:LON ANGLE plc Health £31.9m Potential new analytical protocol using Parsortix
05Oct17 11:46 RNS AGL:LON ANGLE plc Health £31.9m Results of Fundraising
05Oct17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Acquisition and Fundraising
13Sep17 17:36 RNS AGL:LON ANGLE plc Health £31.9m Holding(s) in Company
13Sep17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Exclusive worldwide option over megakaryocyte IP
11Sep17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Co-Marketing Partnership with QIAGEN
05Sep17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Change of Adviser
27Jul17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Preliminary Results
06Jul17 10:05 RNS AGL:LON ANGLE plc Health £31.9m Notice of Results
04Jul17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Successful Headline Data in Ovarian Cancer Studies
15Jun17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Parsortix breakthrough in prostate cancer
03May17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Business Update
04Apr17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Holding(s) in Company
03Apr17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Parsortix enables analysis in head and neck cancer
30Mar17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Prostate Cancer Update
14Feb17 11:39 EQS AGL:LON ANGLE plc Health £31.9m Edison issues outlook on Angle
26Jan17 07:01 RNS AGL:LON ANGLE plc Health £31.9m Interim Evaluation of Ovarian Cancer Study
26Jan17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Interim Results
04Jan17 07:00 RNS AGL:LON ANGLE plc Health £31.9m Notice of Results
28Nov16 07:00 RNS AGL:LON ANGLE plc Health £31.9m ISSUE OF SHARE OPTIONS
24Nov16 14:48 RNS AGL:LON ANGLE plc Health £31.9m Result of GM
04Nov16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Barts Research Supports Potential Use of Parsortix
01Nov16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Notice of GM
27Oct16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Director's share purchase
07Oct16 11:57 RNS LGEN:LON, AGL:LON ANGLE plc, Legal & General Group Plc Various Various Holding(s) in Company
04Oct16 16:35 RNS AGL:LON ANGLE plc Health £31.9m Result of AGM
30Sep16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Research published in Clinical Chemistry
19Sep16 11:14 RNS AGL:LON ANGLE plc Health £31.9m Issue of Equity
09Sep16 16:12 RNS AGL:LON ANGLE plc Health £31.9m Annual Report and Accounts and Notice of AGM
27Jul16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Initiation of 200 patient US ovarian cancer study
19Jul16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Initiation of European ovarian cancer study
15Jul16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Notice of Results
15Jul16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Parsortix gaining traction at EACR Conference
01Jun16 15:04 RNS AGL:LON ANGLE plc Health £31.9m Holding(s) in Company
31May16 16:36 RNS LGEN:LON, AGL:LON ANGLE plc, Legal & General Group Plc Various Various Holding(s) in Company
25May16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Placing
25May16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Cancer Research UK Contract
18Apr16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Parsortix potential in metastatic breast cancer
21Mar16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Parsortix potential for prostate cancer detection
09Mar16 07:00 RNS AGL:LON ANGLE plc Health £31.9m European patent grant for Parsortix
28Jan16 07:00 RNS AGL:LON ANGLE plc Health £31.9m Interim Results
27Jan16 10:42 RNS AGL:LON ANGLE plc Health £31.9m Notice of Interim Results
25Jan16 07:00 RNS AGL:LON ANGLE plc Health £31.9m UKE publishes evaluation of Parsortix
22Dec15 07:00 RNS AGL:LON ANGLE plc Health £31.9m Completion of Geomerics Transaction
Date / Time Source Company % Chg
31May19 07:00 RNS ANGLE plc -2.00%
Positive Results from FDA Clinical Study
26Apr19 07:00 RNS ANGLE plc -2.00%
IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
18Apr19 07:00 RNS-R ANGLE plc -2.00%
Parsortix used in new cancer assessment technique
12Apr19 07:00 RNS-R ANGLE plc -2.00%
LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04Apr19 07:00 RNS ANGLE plc -2.00%
AACR 2019
11Mar19 07:00 RNS ANGLE plc, Legal & General Group Plc -0.16%
Holding(s) in Company
07Mar19 07:00 RNS ANGLE plc -2.00%
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28Feb19 07:00 RNS ANGLE plc -2.00%
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25Feb19 07:00 RNS ANGLE plc -2.00%
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11Feb19 07:00 RNS ANGLE plc -2.00%
Research into role of immune cells in cancer
31Jan19 07:00 RNS ANGLE plc -2.00%
Interim Results
29Jan19 07:00 RNS-R ANGLE plc -2.00%
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
10Jan19 16:01 RNS ANGLE plc -2.00%
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09Jan19 07:00 RNS ANGLE plc -2.00%
Notice of Results
21Dec18 07:00 RNS ANGLE plc -2.00%
Issue of LTIP Options and Share Options
28Nov18 07:00 RNS-R ANGLE plc -2.00%
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13Nov18 17:10 RNS ANGLE plc -2.00%
Holding(s) in Company
05Nov18 07:00 RNS ANGLE plc -2.00%
Acquisition of outstanding shares
01Nov18 07:00 RNS ANGLE plc -2.00%
Appointment of Dr Jan Groen as NED
30Oct18 16:21 RNS ANGLE plc -2.00%
Result of AGM
29Oct18 07:00 RNS ANGLE plc -2.00%
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25Oct18 07:00 RNS ANGLE plc -2.00%
Good Progress with FDA Studies
09Oct18 07:00 RNS ANGLE plc -2.00%
Notice of AGM
25Jul18 07:00 RNS ANGLE plc -2.00%
Preliminary Results for year ended 30 April 2018
24Jul18 17:42 RNS ANGLE plc -2.00%
EIS/VCT Advance Assurance and Total Voting Rights
18Jul18 10:34 RNS ANGLE plc -2.00%
Result of General Meeting
02Jul18 07:00 RNS ANGLE plc -2.00%
Notice of Preliminary Results
25Jun18 18:20 RNS ANGLE plc -2.00%
Results of Fundraising
25Jun18 14:58 RNS ANGLE plc -2.00%
Close of Accelerated Bookbuild
25Jun18 07:50 RNS ANGLE plc -2.00%
Proposed Placing of New Ordinary Shares
04Jun18 07:00 RNS ANGLE plc -2.00%
ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
19Apr18 07:00 RNS ANGLE plc -2.00%
Breakthrough Research with Parsortix
05Apr18 07:00 RNS ANGLE plc -2.00%
First patient enrolled in FDA study
26Mar18 07:00 RNS ANGLE plc -2.00%
Research Update
06Feb18 07:00 RNS ANGLE plc -2.00%
ANGLE plc: RESEARCH GRANT FROM ABBOTT
31Jan18 07:00 RNS ANGLE plc -2.00%
Interim Results
10Jan18 10:16 RNS ANGLE plc -2.00%
Notice of Results
08Jan18 07:00 RNS ANGLE plc -2.00%
ANGLE plc:Prostate cancer ARV7 treatment biomarker
27Dec17 11:49 RNS ANGLE plc -2.00%
Holding(s) in Company
12Dec17 07:00 RNS ANGLE plc -2.00%
Transfer of Lock-in Shares
08Dec17 07:00 RNS ANGLE plc -2.00%
PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER
23Nov17 07:00 RNS ANGLE plc -2.00%
PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER
17Nov17 16:06 RNS ANGLE plc -2.00%
Holding(s) in Company
16Nov17 08:23 RNS ANGLE plc -2.00%
Total Voting Rights and Covington Subscription
06Nov17 07:00 RNS ANGLE plc -2.00%
Holding(s) in Company
06Nov17 07:00 RNS ANGLE plc -2.00%
Holding(s) in Company
06Nov17 07:00 RNS ANGLE plc, Legal & General Group Plc -0.16%
Holding(s) in Company
02Nov17 10:04 RNS ANGLE plc -2.00%
Holding(s) in Company
01Nov17 08:12 RNS ANGLE plc -2.00%
ANGLE: Completion of Fundraising and Acquisition
31Oct17 14:18 RNS ANGLE plc -2.00%
Result of AGM
30Oct17 10:31 RNS ANGLE plc -2.00%
Result of General Meeting
26Oct17 08:10 RNS ANGLE plc -2.00%
Total Voting Rights
23Oct17 07:00 RNS ANGLE plc -2.00%
Parsortix harvests cancer cells from bone marrow
20Oct17 15:05 RNS ANGLE plc -2.00%
Notice of AGM
12Oct17 07:00 RNS ANGLE plc -2.00%
Proposed further subscription for £2.8 million
09Oct17 07:02 RNS ANGLE plc -2.00%
CTCs harvested with Parsortix grown in laboratory
09Oct17 07:01 RNS ANGLE plc -2.00%
Potential new analytical protocol using Parsortix
05Oct17 11:46 RNS ANGLE plc -2.00%
Results of Fundraising
05Oct17 07:00 RNS ANGLE plc -2.00%
Acquisition and Fundraising
13Sep17 17:36 RNS ANGLE plc -2.00%
Holding(s) in Company
13Sep17 07:00 RNS ANGLE plc -2.00%
Exclusive worldwide option over megakaryocyte IP
11Sep17 07:00 RNS ANGLE plc -2.00%
Co-Marketing Partnership with QIAGEN
05Sep17 07:00 RNS ANGLE plc -2.00%
Change of Adviser
27Jul17 07:00 RNS ANGLE plc -2.00%
Preliminary Results
06Jul17 10:05 RNS ANGLE plc -2.00%
Notice of Results
04Jul17 07:00 RNS ANGLE plc -2.00%
Successful Headline Data in Ovarian Cancer Studies
15Jun17 07:00 RNS ANGLE plc -2.00%
Parsortix breakthrough in prostate cancer
03May17 07:00 RNS ANGLE plc -2.00%
Business Update
04Apr17 07:00 RNS ANGLE plc -2.00%
Holding(s) in Company
03Apr17 07:00 RNS ANGLE plc -2.00%
Parsortix enables analysis in head and neck cancer
30Mar17 07:00 RNS ANGLE plc -2.00%
Prostate Cancer Update
14Feb17 11:39 EQS ANGLE plc -2.00%
Edison issues outlook on Angle
26Jan17 07:01 RNS ANGLE plc -2.00%
Interim Evaluation of Ovarian Cancer Study
26Jan17 07:00 RNS ANGLE plc -2.00%
Interim Results
04Jan17 07:00 RNS ANGLE plc -2.00%
Notice of Results
28Nov16 07:00 RNS ANGLE plc -2.00%
ISSUE OF SHARE OPTIONS
24Nov16 14:48 RNS ANGLE plc -2.00%
Result of GM
04Nov16 07:00 RNS ANGLE plc -2.00%
Barts Research Supports Potential Use of Parsortix
01Nov16 07:00 RNS ANGLE plc -2.00%
Notice of GM
27Oct16 07:00 RNS ANGLE plc -2.00%
Director's share purchase
07Oct16 11:57 RNS ANGLE plc, Legal & General Group Plc -0.16%
Holding(s) in Company
04Oct16 16:35 RNS ANGLE plc -2.00%
Result of AGM
30Sep16 07:00 RNS ANGLE plc -2.00%
Research published in Clinical Chemistry
19Sep16 11:14 RNS ANGLE plc -2.00%
Issue of Equity
09Sep16 16:12 RNS ANGLE plc -2.00%
Annual Report and Accounts and Notice of AGM
27Jul16 07:00 RNS ANGLE plc -2.00%
Initiation of 200 patient US ovarian cancer study
19Jul16 07:00 RNS ANGLE plc -2.00%
Initiation of European ovarian cancer study
15Jul16 07:00 RNS ANGLE plc -2.00%
Notice of Results
15Jul16 07:00 RNS ANGLE plc -2.00%
Parsortix gaining traction at EACR Conference
01Jun16 15:04 RNS ANGLE plc -2.00%
Holding(s) in Company
31May16 16:36 RNS ANGLE plc, Legal & General Group Plc -0.16%
Holding(s) in Company
25May16 07:00 RNS ANGLE plc -2.00%
Placing
25May16 07:00 RNS ANGLE plc -2.00%
Cancer Research UK Contract
18Apr16 07:00 RNS ANGLE plc -2.00%
Parsortix potential in metastatic breast cancer
21Mar16 07:00 RNS ANGLE plc -2.00%
Parsortix potential for prostate cancer detection
09Mar16 07:00 RNS ANGLE plc -2.00%
European patent grant for Parsortix
28Jan16 07:00 RNS ANGLE plc -2.00%
Interim Results
27Jan16 10:42 RNS ANGLE plc -2.00%
Notice of Interim Results
25Jan16 07:00 RNS ANGLE plc -2.00%
UKE publishes evaluation of Parsortix
22Dec15 07:00 RNS ANGLE plc -2.00%
Completion of Geomerics Transaction
Date / Time Company % Chg
31May19 07:00 ANGLE plc -2.00%
Positive Results from FDA Clinical Study
26Apr19 07:00 ANGLE plc -2.00%
IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
18Apr19 07:00 ANGLE plc -2.00%
Parsortix used in new cancer assessment technique
12Apr19 07:00 ANGLE plc -2.00%
LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04Apr19 07:00 ANGLE plc -2.00%
AACR 2019
11Mar19 07:00 AGL LSE,LGEN LSE -0.16%
Holding(s) in Company
07Mar19 07:00 ANGLE plc -2.00%
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28Feb19 07:00 ANGLE plc -2.00%
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25Feb19 07:00 ANGLE plc -2.00%
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11Feb19 07:00 ANGLE plc -2.00%
Research into role of immune cells in cancer
31Jan19 07:00 ANGLE plc -2.00%
Interim Results
29Jan19 07:00 ANGLE plc -2.00%
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
10Jan19 16:01 ANGLE plc -2.00%
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09Jan19 07:00 ANGLE plc -2.00%
Notice of Results
21Dec18 07:00 ANGLE plc -2.00%
Issue of LTIP Options and Share Options
28Nov18 07:00 ANGLE plc -2.00%
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13Nov18 17:10 ANGLE plc -2.00%
Holding(s) in Company
05Nov18 07:00 ANGLE plc -2.00%
Acquisition of outstanding shares
01Nov18 07:00 ANGLE plc -2.00%
Appointment of Dr Jan Groen as NED
30Oct18 16:21 ANGLE plc -2.00%
Result of AGM
29Oct18 07:00 ANGLE plc -2.00%
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25Oct18 07:00 ANGLE plc -2.00%
Good Progress with FDA Studies
09Oct18 07:00 ANGLE plc -2.00%
Notice of AGM
25Jul18 07:00 ANGLE plc -2.00%
Preliminary Results for year ended 30 April 2018
24Jul18 17:42 ANGLE plc -2.00%
EIS/VCT Advance Assurance and Total Voting Rights
18Jul18 10:34 ANGLE plc -2.00%
Result of General Meeting
02Jul18 07:00 ANGLE plc -2.00%
Notice of Preliminary Results
25Jun18 18:20 ANGLE plc -2.00%
Results of Fundraising
25Jun18 14:58 ANGLE plc -2.00%
Close of Accelerated Bookbuild
25Jun18 07:50 ANGLE plc -2.00%
Proposed Placing of New Ordinary Shares
04Jun18 07:00 ANGLE plc -2.00%
ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
19Apr18 07:00 ANGLE plc -2.00%
Breakthrough Research with Parsortix
05Apr18 07:00 ANGLE plc -2.00%
First patient enrolled in FDA study
26Mar18 07:00 ANGLE plc -2.00%
Research Update
06Feb18 07:00 ANGLE plc -2.00%
ANGLE plc: RESEARCH GRANT FROM ABBOTT
31Jan18 07:00 ANGLE plc -2.00%
Interim Results
10Jan18 10:16 ANGLE plc -2.00%
Notice of Results
08Jan18 07:00 ANGLE plc -2.00%
ANGLE plc:Prostate cancer ARV7 treatment biomarker
27Dec17 11:49 ANGLE plc -2.00%
Holding(s) in Company
12Dec17 07:00 ANGLE plc -2.00%
Transfer of Lock-in Shares
08Dec17 07:00 ANGLE plc -2.00%
PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER
23Nov17 07:00 ANGLE plc -2.00%
PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER
17Nov17 16:06 ANGLE plc -2.00%
Holding(s) in Company
16Nov17 08:23 ANGLE plc -2.00%
Total Voting Rights and Covington Subscription
06Nov17 07:00 ANGLE plc -2.00%
Holding(s) in Company
06Nov17 07:00 ANGLE plc -2.00%
Holding(s) in Company
06Nov17 07:00 AGL LSE,LGEN LSE -0.16%
Holding(s) in Company
02Nov17 10:04 ANGLE plc -2.00%
Holding(s) in Company
01Nov17 08:12 ANGLE plc -2.00%
ANGLE: Completion of Fundraising and Acquisition
31Oct17 14:18 ANGLE plc -2.00%
Result of AGM
30Oct17 10:31 ANGLE plc -2.00%
Result of General Meeting
26Oct17 08:10 ANGLE plc -2.00%
Total Voting Rights
23Oct17 07:00 ANGLE plc -2.00%
Parsortix harvests cancer cells from bone marrow
20Oct17 15:05 ANGLE plc -2.00%
Notice of AGM
12Oct17 07:00 ANGLE plc -2.00%
Proposed further subscription for £2.8 million
09Oct17 07:02 ANGLE plc -2.00%
CTCs harvested with Parsortix grown in laboratory
09Oct17 07:01 ANGLE plc -2.00%
Potential new analytical protocol using Parsortix
05Oct17 11:46 ANGLE plc -2.00%
Results of Fundraising
05Oct17 07:00 ANGLE plc -2.00%
Acquisition and Fundraising
13Sep17 17:36 ANGLE plc -2.00%
Holding(s) in Company
13Sep17 07:00 ANGLE plc -2.00%
Exclusive worldwide option over megakaryocyte IP
11Sep17 07:00 ANGLE plc -2.00%
Co-Marketing Partnership with QIAGEN
05Sep17 07:00 ANGLE plc -2.00%
Change of Adviser
27Jul17 07:00 ANGLE plc -2.00%
Preliminary Results
06Jul17 10:05 ANGLE plc -2.00%
Notice of Results
04Jul17 07:00 ANGLE plc -2.00%
Successful Headline Data in Ovarian Cancer Studies
15Jun17 07:00 ANGLE plc -2.00%
Parsortix breakthrough in prostate cancer
03May17 07:00 ANGLE plc -2.00%
Business Update
04Apr17 07:00 ANGLE plc -2.00%
Holding(s) in Company
03Apr17 07:00 ANGLE plc -2.00%
Parsortix enables analysis in head and neck cancer
30Mar17 07:00 ANGLE plc -2.00%
Prostate Cancer Update
14Feb17 11:39 ANGLE plc -2.00%
Edison issues outlook on Angle
26Jan17 07:01 ANGLE plc -2.00%
Interim Evaluation of Ovarian Cancer Study
26Jan17 07:00 ANGLE plc -2.00%
Interim Results
04Jan17 07:00 ANGLE plc -2.00%
Notice of Results
28Nov16 07:00 ANGLE plc -2.00%
ISSUE OF SHARE OPTIONS
24Nov16 14:48 ANGLE plc -2.00%
Result of GM
04Nov16 07:00 ANGLE plc -2.00%
Barts Research Supports Potential Use of Parsortix
01Nov16 07:00 ANGLE plc -2.00%
Notice of GM
27Oct16 07:00 ANGLE plc -2.00%
Director's share purchase
07Oct16 11:57 AGL LSE,LGEN LSE -0.16%
Holding(s) in Company
04Oct16 16:35 ANGLE plc -2.00%
Result of AGM
30Sep16 07:00 ANGLE plc -2.00%
Research published in Clinical Chemistry
19Sep16 11:14 ANGLE plc -2.00%
Issue of Equity
09Sep16 16:12 ANGLE plc -2.00%
Annual Report and Accounts and Notice of AGM
27Jul16 07:00 ANGLE plc -2.00%
Initiation of 200 patient US ovarian cancer study
19Jul16 07:00 ANGLE plc -2.00%
Initiation of European ovarian cancer study
15Jul16 07:00 ANGLE plc -2.00%
Notice of Results
15Jul16 07:00 ANGLE plc -2.00%
Parsortix gaining traction at EACR Conference
01Jun16 15:04 ANGLE plc -2.00%
Holding(s) in Company
31May16 16:36 AGL LSE,LGEN LSE -0.16%
Holding(s) in Company
25May16 07:00 ANGLE plc -2.00%
Placing
25May16 07:00 ANGLE plc -2.00%
Cancer Research UK Contract
18Apr16 07:00 ANGLE plc -2.00%
Parsortix potential in metastatic breast cancer
21Mar16 07:00 ANGLE plc -2.00%
Parsortix potential for prostate cancer detection
09Mar16 07:00 ANGLE plc -2.00%
European patent grant for Parsortix
28Jan16 07:00 ANGLE plc -2.00%
Interim Results
27Jan16 10:42 ANGLE plc -2.00%
Notice of Interim Results
25Jan16 07:00 ANGLE plc -2.00%
UKE publishes evaluation of Parsortix
22Dec15 07:00 ANGLE plc -2.00%
Completion of Geomerics Transaction